REVB Q1 2025 Earnings — Revelation Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

REVBRevelation Biosciences, Inc.

$2M

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$7,221

Operating Income

-$2M

Net Income

-$2M

EPS (Diluted)

$-2.11

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$223,455

Balance Sheet

Total Assets

$4M

Total Liabilities

$1M

Stockholders' Equity

$3M

Cash & Equivalents

$4M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$7,221	-$6,262	-15.3%
Operating Income	-$2M	-$2M	-10.1%
Net Income	-$2M	-$3M	+23.5%